Molecular Biomarkers for Cancer Detection and Management Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4162695
- 130 Pages
- January 2020
- Medical Devices
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Molecular Biomarkers for Cancer Detection and Management market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Molecular Biomarkers for Cancer Detection and Management market segmented into
Screening, Detection, Risk Assessment, and Monitoring Biomarkers
Prognosis and Prediction Biomarkers
Companion Diagnostic Biomarkers
Based on the end-use, the global Molecular Biomarkers for Cancer Detection and Management market classified into
Hospital
Research Institutions
Others
Based on geography, the global Molecular Biomarkers for Cancer Detection and Management market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Alere
Atossa Genetics
Biophysical
Abbott
BioCept
BioTheranostics
DiagnoCure
GenomeDx
Genomic Health
Gen-Probe
Life Technologies
20/20 GeneSystems
Cynvenio
Dako (Agilent)
Epic Sciences
Foundation Medicine
Genomic Health
Molecular Response
Nodality
PGD
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL MOLECULAR BIOMARKERS FOR CANCER DETECTION AND MANAGEMENT INDUSTRY
2.1 Summary about Molecular Biomarkers for Cancer Detection and Management Industry
2.2 Molecular Biomarkers for Cancer Detection and Management Market Trends
2.2.1 Molecular Biomarkers for Cancer Detection and Management Production & Consumption Trends
2.2.2 Molecular Biomarkers for Cancer Detection and Management Demand Structure Trends
2.3 Molecular Biomarkers for Cancer Detection and Management Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Screening, Detection, Risk Assessment, and Monitoring Biomarkers
4.2.2 Prognosis and Prediction Biomarkers
4.2.3 Companion Diagnostic Biomarkers
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospital
4.3.2 Research Institutions
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Screening, Detection, Risk Assessment, and Monitoring Biomarkers
5.2.2 Prognosis and Prediction Biomarkers
5.2.3 Companion Diagnostic Biomarkers
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospital
5.3.2 Research Institutions
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Screening, Detection, Risk Assessment, and Monitoring Biomarkers
6.2.2 Prognosis and Prediction Biomarkers
6.2.3 Companion Diagnostic Biomarkers
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospital
6.3.2 Research Institutions
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Screening, Detection, Risk Assessment, and Monitoring Biomarkers
7.2.2 Prognosis and Prediction Biomarkers
7.2.3 Companion Diagnostic Biomarkers
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospital
7.3.2 Research Institutions
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Screening, Detection, Risk Assessment, and Monitoring Biomarkers
8.2.2 Prognosis and Prediction Biomarkers
8.2.3 Companion Diagnostic Biomarkers
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospital
8.3.2 Research Institutions
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Screening, Detection, Risk Assessment, and Monitoring Biomarkers
9.2.2 Prognosis and Prediction Biomarkers
9.2.3 Companion Diagnostic Biomarkers
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospital
9.3.2 Research Institutions
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Alere
10.1.2 Atossa Genetics
10.1.3 Biophysical
10.1.4 Abbott
10.1.5 BioCept
10.1.6 BioTheranostics
10.1.7 DiagnoCure
10.1.8 GenomeDx
10.1.9 Genomic Health
10.1.10 Gen-Probe
10.1.11 Life Technologies
10.1.12 20/20 GeneSystems
10.1.13 Cynvenio
10.1.14 Dako (Agilent)
10.1.15 Epic Sciences
10.1.16 Foundation Medicine
10.1.17 Genomic Health
10.1.18 Molecular Response
10.1.19 Nodality
10.1.20 PGD
10.2 Molecular Biomarkers for Cancer Detection and Management Sales Date of Major Players (2017-2020e)
10.2.1 Alere
10.2.2 Atossa Genetics
10.2.3 Biophysical
10.2.4 Abbott
10.2.5 BioCept
10.2.6 BioTheranostics
10.2.7 DiagnoCure
10.2.8 GenomeDx
10.2.9 Genomic Health
10.2.10 Gen-Probe
10.2.11 Life Technologies
10.2.12 20/20 GeneSystems
10.2.13 Cynvenio
10.2.14 Dako (Agilent)
10.2.15 Epic Sciences
10.2.16 Foundation Medicine
10.2.17 Genomic Health
10.2.18 Molecular Response
10.2.19 Nodality
10.2.20 PGD
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Molecular Biomarkers for Cancer Detection and Management Product Type Overview
2.Table Molecular Biomarkers for Cancer Detection and Management Product Type Market Share List
3.Table Molecular Biomarkers for Cancer Detection and Management Product Type of Major Players
4.Table Brief Introduction of Alere
5.Table Brief Introduction of Atossa Genetics
6.Table Brief Introduction of Biophysical
7.Table Brief Introduction of Abbott
8.Table Brief Introduction of BioCept
9.Table Brief Introduction of BioTheranostics
10.Table Brief Introduction of DiagnoCure
11.Table Brief Introduction of GenomeDx
12.Table Brief Introduction of Genomic Health
13.Table Brief Introduction of Gen-Probe
14.Table Brief Introduction of Life Technologies
15.Table Brief Introduction of 20/20 GeneSystems
16.Table Brief Introduction of Cynvenio
17.Table Brief Introduction of Dako (Agilent)
18.Table Brief Introduction of Epic Sciences
19.Table Brief Introduction of Foundation Medicine
20.Table Brief Introduction of Genomic Health
21.Table Brief Introduction of Molecular Response
22.Table Brief Introduction of Nodality
23.Table Brief Introduction of PGD
24.Table Products & Services of Alere
25.Table Products & Services of Atossa Genetics
26.Table Products & Services of Biophysical
27.Table Products & Services of Abbott
28.Table Products & Services of BioCept
29.Table Products & Services of BioTheranostics
30.Table Products & Services of DiagnoCure
31.Table Products & Services of GenomeDx
32.Table Products & Services of Genomic Health
33.Table Products & Services of Gen-Probe
34.Table Products & Services of Life Technologies
35.Table Products & Services of 20/20 GeneSystems
36.Table Products & Services of Cynvenio
37.Table Products & Services of Dako (Agilent)
38.Table Products & Services of Epic Sciences
39.Table Products & Services of Foundation Medicine
40.Table Products & Services of Genomic Health
41.Table Products & Services of Molecular Response
42.Table Products & Services of Nodality
43.Table Products & Services of PGD
44.Table Market Distribution of Major Players
45.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
46.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
47.Table Global Molecular Biomarkers for Cancer Detection and Management Market Forecast (Million USD) by Region 2021f-2026f
48.Table Global Molecular Biomarkers for Cancer Detection and Management Market Forecast (Million USD) Share by Region 2021f-2026f
49.Table Global Molecular Biomarkers for Cancer Detection and Management Market Forecast (Million USD) by Demand 2021f-2026f
50.Table Global Molecular Biomarkers for Cancer Detection and Management Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
